Identification of small molecular compounds and fabrication of its aqueous solution by laser-ablation, expanding primordial cartilage

Osteoarthritis and Cartilage

Volumn 19, Issue 2, 2011, Pages 233-241

  Ikegami, D ^a   Iwai, T ^a   Ryo, S ^b   Gu, N ^c   Sugiyama, T ^d   Oh, I ^b   Yoshikawa, H ^a   Tsumaki, N ^a,e  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ABsize Inc 104 S Cube   (Japan)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Bone morphogenetic proteins; Chondrocytes; Laser ablation; Small molecular compounds

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (5 BENZOL[1,3]DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE HYDRATE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; A 83 01; COLLAGEN TYPE 10; COLLAGENASE; D 4476; FIBROBLAST GROWTH FACTOR 2; GROWTH DIFFERENTIATION FACTOR 5; LY 364947; LY 364974; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SB 505124; SB 525334; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CARTILAGE; COLLOID; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; EMBRYO; EXPLANT; LASER SURGERY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PERICHONDRIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE EXPANSION; TISSUE GROWTH;

ANIMALS; BENZAMIDES; BONE MORPHOGENETIC PROTEINS; CARTILAGE; DIOXOLES; LASERS; METATARSAL BONES; MICE; ORGAN CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 79151486108     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.11.007     Document Type: Article

References (23)

1. Erlebacher A., Filvaroff E.H., Gitelman S.E., Derynck R. Toward a molecular understanding of skeletal development. Cell 1995, 80:371-378.
2. Buckwalter J.A., Mankin H.J. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 1998, 47:487-504.
3. Horton W.E., Bennion P., Yang L. Cellular, molecular, and matrix changes in cartilage during aging and osteoarthritis. J Musculoskelet Neuronal Interact 2006, 6:379-381.
4. Lohmander L.S., Roos E.M. Clinical update: treating osteoarthritis. Lancet 2007, 370:2082-2084.
5. Getgood A., Brooks R., Fortier L., Rushton N. Articular cartilage tissue engineering: today's research, tomorrow's practice?. J Bone Joint Surg Br 2009, 91:565-576.
6. Alvarez J., Horton J., Sohn P., Serra R. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation. Dev Dyn 2001, 221:311-321.
7. Mukherjee A., Dong S.S., Clemens T., Alvarez J., Serra R. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. Mech Dev 2005, 122:557-571.
8. Haaijman A., D'Souza R.N., Bronckers A.L., Goei S.W., Burger E.H. OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro. J Bone Miner Res 1997, 12:1815-1823.
9. Miljkovic N.D., Cooper G.M., Marra K.G. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage 2008, 16:1121-1130.
10. Asahi T., Sugiyama T., Masuhara H. Laser fabrication and spectroscopy of organic nanoparticles. Acc Chem Res 2008, 41:1790-1798.
11. Sugiyama T., Ryo S., Oh I., Asahi T., Masuhara H. Nanosecond laser preparation of C60 aqueous nanocolloids. J Photochem Photobiol A Chem 2009, 207:7-12.
12. Tamaki Y., Asahi T., Masuhara H. Nanoparticle formation of vanadyl phthalocyanine by laser ablation of its crystalline powder in a poor solvent. J Phys Chem A 2002, 106:2135-2139.
13. Haaijman A., Karperien M., Lanske B., Hendriks J., Lowik C.W., Bronckers A.L., et al. Inhibition of terminal chondrocyte differentiation by bone morphogenetic protein 7 (OP-1) in vitro depends on the periarticular region but is independent of parathyroid hormone-related peptide. Bone 1999, 25:397-404.
14. Thesingh C.W., Burger E.H. The role of mesenchyme in embryonic long bones as early deposition site for osteoclast progenitor cells. Dev Biol 1983, 95:429-438.
15. Burdette J.E., Jeruss J.S., Kurley S.J., Lee E.J., Woodruff T.K. Activin A mediates growth inhibition and cell cycle arrest through smads in human breast cancer cells. Cancer Res 2005, 65:7968-7975.
16. Li T.F., O'Keefe R.J., Chen D. TGF-beta signaling in chondrocytes. Front Biosci 2005, 10:681-688.
17. Issack P.S., DiCesare P.E. Recent advances toward the clinical application of bone morphogenetic proteins in bone and cartilage repair. Am J Orthop 2003, 32:429-436.
18. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008, 2:1-13.
19. Tsumaki N., Nakase T., Miyaji T., Kakiuchi M., Kimura T., Ochi T., et al. Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res 2002, 17:898-906.
20. Tsumaki N., Tanaka K., Arikawa-Hirasawa E., Nakase T., Kimura T., Thomas J.T., et al. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 1999, 144:161-173.
21. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84-A:2123-2134.
22. Friedlaender G.E., Perry C.R., Cole J.D., Cook S.D., Cierny G., Muschler G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83-A(Suppl 1):S151-S158.
23. Burkus J.K., Gornet M.F., Dickman C.A., Zdeblick T.A. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002, 15:337-349.